A Study on Mayo Clinic Patients with Friedreich Ataxia

Overview

About this study

The purpose of this study is to create a clinical registry of patients with FRDA seen at Mayo Clinic.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All ages
  • Diagnosis of
  • Seen at Mayo clinic between 1995 and 2013

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ralitza Gavrilova, M.D.

Open for enrollment

Contact information:

Jennifer Kemppainen M.S., LCGC

(507)293-4627

Kemppainen.Jennifer@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available